Vetoquinol
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more
Vetoquinol (VETO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.026x
Based on the latest financial reports, Vetoquinol (VETO) has a cash flow conversion efficiency ratio of 0.026x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.72 Million) by net assets (€567.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vetoquinol - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Vetoquinol's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vetoquinol Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vetoquinol ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
V2 Retail Limited
NSE:V2RETAIL
|
0.284x |
|
Industrie De Nora S.p.A.
LSE:0ABI
|
N/A |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381
|
0.021x |
|
Target Hospitality Corp
NASDAQ:TH
|
0.133x |
|
MIDLAND STS BANCOR.DL-01
F:6HU
|
N/A |
|
Site Centers Corp
NYSE:SITC
|
-0.021x |
|
Xiamen Sunrise Wheel Group Co Ltd
SHE:002593
|
0.029x |
|
Suzhou YourBest New-type Materials Co.Ltd.
SHE:301266
|
-0.128x |
Annual Cash Flow Conversion Efficiency for Vetoquinol (2004–2024)
The table below shows the annual cash flow conversion efficiency of Vetoquinol from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €575.93 Million | €85.83 Million | 0.149x | -12.13% |
| 2023-12-31 | €527.11 Million | €89.39 Million | 0.170x | +30.77% |
| 2022-12-31 | €484.66 Million | €62.85 Million | 0.130x | -36.20% |
| 2021-12-31 | €441.35 Million | €89.72 Million | 0.203x | -18.05% |
| 2020-12-31 | €371.83 Million | €92.23 Million | 0.248x | +84.03% |
| 2019-12-31 | €385.98 Million | €52.02 Million | 0.135x | +29.18% |
| 2018-12-31 | €363.08 Million | €37.88 Million | 0.104x | -15.03% |
| 2017-12-31 | €335.73 Million | €41.23 Million | 0.123x | -10.05% |
| 2016-12-31 | €316.48 Million | €43.20 Million | 0.137x | +1.61% |
| 2015-12-31 | €289.49 Million | €38.90 Million | 0.134x | -12.68% |
| 2014-12-31 | €268.40 Million | €41.30 Million | 0.154x | +29.18% |
| 2013-12-31 | €235.96 Million | €28.11 Million | 0.119x | -20.61% |
| 2012-12-31 | €228.01 Million | €34.21 Million | 0.150x | +5.70% |
| 2011-12-31 | €211.29 Million | €29.99 Million | 0.142x | -23.87% |
| 2010-12-31 | €184.27 Million | €34.36 Million | 0.186x | -27.85% |
| 2009-12-31 | €154.95 Million | €40.05 Million | 0.258x | +61.72% |
| 2008-12-31 | €137.05 Million | €21.90 Million | 0.160x | -45.09% |
| 2007-12-31 | €127.87 Million | €37.22 Million | 0.291x | +38.50% |
| 2006-12-31 | €111.15 Million | €23.36 Million | 0.210x | -39.22% |
| 2005-12-31 | €86.82 Million | €30.01 Million | 0.346x | +19.09% |
| 2004-12-31 | €71.38 Million | €20.72 Million | 0.290x | -- |